The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens

Immunology and Cell Biology

Volumn 93, Issue 2, 2015, Pages 167-176

  Hansell, Chris AH ^a   Maclellan, Lindsay M ^a   Oldham, Rachel S ^a   Doonan, James ^a   Chapple, Katie J ^a   Anderson, Elinor J R ^a   Linington, Christopher ^a   Mcinnes, Iain B ^a   Nibbs, Robert J B ^a   Goodyear, Carl S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL CHEMOKINE RECEPTOR 2; AUTOANTIGEN; BETA CHEMOKINE; CD8 ANTIGEN; CHEMOKINE RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; UNCLASSIFIED DRUG; ANTIBODY; CCBP2 PROTEIN, MOUSE; COLLAGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POLARITY; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TH17 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DEFICIENCY; EXPERIMENTAL ARTHRITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNITY; IMMUNOLOGY; JOINT; LYMPH NODE; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; ANTIBODIES; ARTHRITIS, EXPERIMENTAL; AUTOANTIGENS; COLLAGEN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNITY; IMMUNIZATION; INTERLEUKIN-17; JOINTS; LYMPH NODES; LYMPHOCYTE COUNT; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; RECEPTORS, CHEMOKINE; TH17 CELLS; UP-REGULATION;

EID: 84922679971     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2014.90     Document Type: Article

References (41)

1. Rot A, Andrian von UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928
2. Nibbs RJB, Graham GJ. Immune regulation by atypical chemokine receptors. Nat Rev Immunol 2013; 13: 815-829
3. Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ et al. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 2014; 66: 1-79
4. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD et al. The betachemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158: 867-877
5. Madigan J, Freeman DJ, Menzies F, Forrow S, Nelson SM, Young A et al. Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol 2010; 184: 3202-3212
6. Martinez de la Torre Y, Buracchi C, Borroni EM, Dupor J, Bonecchi R, Nebuloni M et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 2007; 104: 2319-2324
7. Nibbs RJ, Wylie SM, Yang J, Landau NR, Graham GJ. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 1997; 272: 32078-32083
8. McKimmie CS, Fraser AR, Hansell C, Gutiérrez L, Philipsen S, Connell L et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol. 2008; 181: 3353-3363
9. Hansell CAH, Schiering C, Kinstrie R, Ford L, Bordon Y, McInnes IB et al. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 2011; 117: 5413-5424
10. Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I et al. Innate response activator B cells protect against microbial sepsis. Science 2012; 335: 597-601
11. Bonecchi R, Locati M, Galliera E. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol 2004; 172: 4972-4976
12. Weber M, Blair E, Simpson CV, O'Hara M, Blackburn PE, Rot A et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 2004; 15: 2492-2508
13. Fra AM, Locati M, Otero K, Sironi M, Signorelli P, Massardi ML et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol 2003; 170: 2279-2282
14. Galliera E, Jala VR, Trent JO, Bonecchi R, Signorelli P, Lefkowitz RJ et al. beta-Arrestindependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 2004; 279: 25590-25597
15. McCulloch CV, Morrow V, Milasta S, Comerford I, Milligan G, Graham GJ et al. Multiple roles for the C-terminal tail of the chemokine scavenger D6. J Biol Chem 2008; 283: 7972-7982
16. Di Liberto D, Locati M, Caccamo N, Vecchi A, Meraviglia S, Salerno A et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J Exp Med 2008; 205: 2075-2084
17. Jamieson T, Cook DN, Nibbs RJB, Rot A, Nixon C, McLean P et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005; 6: 403-411
18. Martinez de la Torre Y, Locati M, Buracchi C, Dupor J, Cook DN, Bonecchi R et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005; 35: 1342-1346
19. Berres M-L, Trautwein C, Zaldivar MM, Schmitz P, Pauels K, Lira SA et al. The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem 2009; 390: 1039-1045
20. Nibbs RJB, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 2007; 117: 1884-1892
21. Whitehead GS, Wang T, DeGraff LM, Card JW, Lira SA, Graham GJ et al. The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med 2007; 175: 243-249
22. Ansel KM, Harris RBS, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002; 16: 67-76
23. Szekanecz Z, Vegvari A, Szabo Z, Koch AE. Chemokines and chemokine receptors in arthritis. Front Biosci 2010; 2: 153-167
24. Proudfoot AEI, de Souza ALS, Muzio V. The use of chemokine antagonists in EAE models. J Neuroimmunol 2008; 198: 27-30
25. Schall TJ, Proudfoot AEI. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat Rev Immunol 2011; 11: 355-363
26. Liu L, Graham GJ, Damodaran A, Hu T, Lira SA, Sasse M et al. Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 17-21
27. Lee KM, McKimmie CS, Gilchrist DS, Pallas KJ, Nibbs RJ, Garside P et al. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 2011; 118: 6220-6229
28. Sonderegger I, Iezzi G, Maier R, Schmitz N, Kurrer M, Kopf M. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med 2008; 205: 2281-2294
29. Nandakumar K, Holmdahl R. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther 2006; 8: 223
30. Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C et al. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6. Gut 2010; 59: 197-206
31. Singh MD, King V, Baldwin H, Burden D, Thorrat A, Holmes S et al. Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol 2012; 181: 1158-1164
32. Constant S, Sant'Angelo D, Pasqualini T, Taylor T, Levin D, Flavell R et al. Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells. J Immunol 1995; 154: 4915-4923
33. Constant S, Schweitzer N, West J, Ranney P, Bottomly K. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 1995; 155: 3734-3741
34. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 2005; 174: 3781-3788
35. Weber MS, Prod'homme T, Patarroyo JC, Molnarfi N, Karnezis T, Lehmann-Horn K et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 2010; 68: 369-383
36. Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008; 118: 3420-3430
37. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004; 172: 803-811
38. Zhong X, Gao W, Degauque N, Bai C, Lu Y, Kenny J et al. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur J Immunol 2007; 37: 2400-2404
39. MacLellan LM, Montgomery J, Sugiyama F, Kitson SM, Thummler K, Silverman GJ et al. Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis. Arthritis Rheum 2011; 63: 3897-3907
40. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997; 40: 249-260
41. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995; 63: 17-27